

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.37970987 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.37970987 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.11188947 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.11188947 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.65918336 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.16545964 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.09956885 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.09956885 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.09956885 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.04344455 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.93546092 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.92773120 |
| 13 | angiotensin maturation (GO:0002003) | 5.91624219 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.89301970 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.72856001 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.69712574 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.68570793 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.62804539 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.58797461 |
| 20 | negative regulation of cell killing (GO:0031342) | 5.58797461 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.58404898 |
| 22 | urea cycle (GO:0000050) | 5.54903770 |
| 23 | urea metabolic process (GO:0019627) | 5.54903770 |
| 24 | cysteine metabolic process (GO:0006534) | 5.41738020 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34545430 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.28751712 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26450701 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.09791407 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 5.03607901 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.01238909 |
| 31 | homocysteine metabolic process (GO:0050667) | 5.00973219 |
| 32 | tolerance induction (GO:0002507) | 4.96691212 |
| 33 | bile acid metabolic process (GO:0008206) | 4.93523791 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.92380415 |
| 35 | protein carboxylation (GO:0018214) | 4.92380415 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91614354 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.88576273 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.86156377 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.85393187 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.84805152 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.84465385 |
| 42 | complement activation, alternative pathway (GO:0006957) | 4.84084328 |
| 43 | lysine metabolic process (GO:0006553) | 4.78566353 |
| 44 | lysine catabolic process (GO:0006554) | 4.78566353 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.76420640 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 4.67219868 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.63863760 |
| 48 | drug catabolic process (GO:0042737) | 4.63730240 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.63587543 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.63429403 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.61896288 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.61896288 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.60233416 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.60233416 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.58997498 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.54955997 |
| 57 | macromolecular complex remodeling (GO:0034367) | 4.54955997 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 4.54955997 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.53369416 |
| 60 | regulation of complement activation (GO:0030449) | 4.53080493 |
| 61 | phospholipid efflux (GO:0033700) | 4.52671701 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.52597762 |
| 63 | tyrosine metabolic process (GO:0006570) | 4.50884341 |
| 64 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.42540696 |
| 65 | cellular glucuronidation (GO:0052695) | 4.37111386 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.31942310 |
| 67 | regulation of cellular extravasation (GO:0002691) | 4.28838726 |
| 68 | glutamate metabolic process (GO:0006536) | 4.27310108 |
| 69 | regulation of bile acid biosynthetic process (GO:0070857) | 4.27235814 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24224250 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24224250 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 4.24224250 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24224250 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 4.24224250 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24224250 |
| 76 | amine catabolic process (GO:0009310) | 4.22022376 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 4.22022376 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 4.21033930 |
| 79 | coenzyme catabolic process (GO:0009109) | 4.20346114 |
| 80 | glycine metabolic process (GO:0006544) | 4.20229110 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 4.15014189 |
| 82 | cholesterol efflux (GO:0033344) | 4.14423107 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 4.13227726 |
| 84 | intestinal cholesterol absorption (GO:0030299) | 4.12763791 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.12747052 |
| 86 | detection of other organism (GO:0098543) | 4.12713920 |
| 87 | benzene-containing compound metabolic process (GO:0042537) | 4.09506318 |
| 88 | flavonoid metabolic process (GO:0009812) | 4.07413321 |
| 89 | plasma lipoprotein particle clearance (GO:0034381) | 4.06711042 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 4.03209802 |
| 91 | detection of bacterium (GO:0016045) | 4.03145902 |
| 92 | ethanol oxidation (GO:0006069) | 4.01890699 |
| 93 | ketone body metabolic process (GO:1902224) | 4.00828165 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 4.00035337 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.99057872 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.98112624 |
| 97 | drug transmembrane transport (GO:0006855) | 3.96633908 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.94196831 |
| 99 | glucuronate metabolic process (GO:0019585) | 3.91565522 |
| 100 | uronic acid metabolic process (GO:0006063) | 3.91565522 |
| 101 | regulation of guanylate cyclase activity (GO:0031282) | 3.90203336 |
| 102 | arginine metabolic process (GO:0006525) | 3.90088092 |
| 103 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.88984944 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86288079 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86288079 |
| 106 | short-chain fatty acid metabolic process (GO:0046459) | 3.85334035 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.84831567 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.84297124 |
| 109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82648556 |
| 110 | urate metabolic process (GO:0046415) | 3.81275429 |
| 111 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80644797 |
| 112 | sterol homeostasis (GO:0055092) | 3.79431570 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.73682387 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.70798230 |
| 115 | organic acid catabolic process (GO:0016054) | 3.70798230 |
| 116 | immunoglobulin mediated immune response (GO:0016064) | 3.70100709 |
| 117 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69484429 |
| 118 | drug metabolic process (GO:0017144) | 3.63821332 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.63649276 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.62944522 |
| 121 | fibrinolysis (GO:0042730) | 3.62109161 |
| 122 | protein-lipid complex assembly (GO:0065005) | 3.61864559 |
| 123 | cofactor catabolic process (GO:0051187) | 3.56961060 |
| 124 | response to interleukin-15 (GO:0070672) | 3.56622238 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 3.53443856 |
| 126 | lipoprotein metabolic process (GO:0042157) | 3.53413193 |
| 127 | macrophage activation involved in immune response (GO:0002281) | 3.51875789 |
| 128 | response to nitrosative stress (GO:0051409) | 3.50993009 |
| 129 | lipoprotein transport (GO:0042953) | 3.46354796 |
| 130 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44463087 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 3.39199837 |
| 132 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.38745964 |
| 133 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38524807 |
| 134 | detection of external biotic stimulus (GO:0098581) | 3.36313055 |
| 135 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.33894351 |
| 136 | cellular response to interleukin-15 (GO:0071350) | 3.24474945 |
| 137 | defense response to protozoan (GO:0042832) | 3.16262562 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 3.13908832 |
| 139 | cellular extravasation (GO:0045123) | 3.12569218 |
| 140 | type I interferon signaling pathway (GO:0060337) | 3.10239595 |
| 141 | cellular response to type I interferon (GO:0071357) | 3.10239595 |
| 142 | response to type I interferon (GO:0034340) | 3.10127603 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 3.09327880 |
| 144 | leukocyte aggregation (GO:0070486) | 3.09258144 |
| 145 | diacylglycerol metabolic process (GO:0046339) | 3.09124249 |
| 146 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.07836774 |
| 147 | hormone catabolic process (GO:0042447) | 3.05089460 |
| 148 | respiratory burst (GO:0045730) | 3.04537732 |
| 149 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.01789624 |
| 150 | actin filament depolymerization (GO:0030042) | 3.01510599 |
| 151 | dendritic cell migration (GO:0036336) | 2.98864004 |
| 152 | neutrophil activation (GO:0042119) | 2.97586029 |
| 153 | NADH metabolic process (GO:0006734) | 2.97389459 |
| 154 | intestinal absorption (GO:0050892) | 2.95083440 |
| 155 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94915967 |
| 156 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92430527 |
| 157 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90989358 |
| 158 | negative regulation of interleukin-12 production (GO:0032695) | 2.89872459 |
| 159 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.88916311 |
| 160 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.88642154 |
| 161 | detection of biotic stimulus (GO:0009595) | 2.84487910 |
| 162 | epoxygenase P450 pathway (GO:0019373) | 2.84252386 |
| 163 | regulation of T cell tolerance induction (GO:0002664) | 2.83421018 |
| 164 | negative T cell selection (GO:0043383) | 2.81822812 |
| 165 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81773814 |
| 166 | negative thymic T cell selection (GO:0045060) | 2.81562525 |
| 167 | NIK/NF-kappaB signaling (GO:0038061) | 2.81533456 |
| 168 | detection of molecule of bacterial origin (GO:0032490) | 2.81498987 |
| 169 | cellular response to reactive nitrogen species (GO:1902170) | 2.81382042 |
| 170 | leukotriene metabolic process (GO:0006691) | 2.79968835 |
| 171 | peptide catabolic process (GO:0043171) | 2.77945976 |
| 172 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.77234590 |
| 173 | B cell mediated immunity (GO:0019724) | 2.76776140 |
| 174 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.76494469 |
| 175 | positive regulation of antigen processing and presentation (GO:0002579) | 2.76485378 |
| 176 | fructose metabolic process (GO:0006000) | 2.76192760 |
| 177 | positive thymic T cell selection (GO:0045059) | 2.75266316 |
| 178 | germinal center formation (GO:0002467) | 2.73414677 |
| 179 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.73357964 |
| 180 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.73161659 |
| 181 | endocrine process (GO:0050886) | 2.73161659 |
| 182 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.73161659 |
| 183 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70265685 |
| 184 | response to host immune response (GO:0052572) | 2.70265685 |
| 185 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.65295428 |
| 186 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.65295428 |
| 187 | regulation of antigen processing and presentation (GO:0002577) | 2.64945395 |
| 188 | response to protozoan (GO:0001562) | 2.64201812 |
| 189 | cytidine metabolic process (GO:0046087) | 2.63562015 |
| 190 | cytidine catabolic process (GO:0006216) | 2.63562015 |
| 191 | cytidine deamination (GO:0009972) | 2.63562015 |
| 192 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.63487994 |
| 193 | granulocyte activation (GO:0036230) | 2.61957558 |
| 194 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61117471 |
| 195 | T cell costimulation (GO:0031295) | 2.60544942 |
| 196 | regulation of regulatory T cell differentiation (GO:0045589) | 2.59858090 |
| 197 | lymphocyte costimulation (GO:0031294) | 2.59374199 |
| 198 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.59305110 |
| 199 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57904179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25037409 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20053020 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.75584235 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.40899778 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.09724776 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85971309 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83235937 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.09009747 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95250178 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77515189 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.51019454 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.39900092 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.39586969 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72915287 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51837132 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50123712 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45007611 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44694033 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40667572 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.37998205 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35922056 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16547729 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15417741 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11820210 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11231699 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.11099685 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.09673872 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06820693 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05896461 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01287743 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6407359 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95901687 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94334959 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94064532 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91435883 |
| 36 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88863288 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86068730 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.85175704 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.80143180 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74588484 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.72581261 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72087610 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70719129 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67230096 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65186015 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64350432 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55733694 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.54634931 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52810191 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50276754 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47465224 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45876094 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44965933 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44828058 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44709269 |
| 56 | * MAF_26560356_Chip-Seq_TH2_Human | 1.43925404 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.41913886 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41314784 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40741513 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40662272 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39691970 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37372795 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37254626 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34334977 |
| 65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33554951 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33340694 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32894161 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31811442 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30213401 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28642704 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26967282 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24512194 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24153144 |
| 74 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23191909 |
| 75 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21318307 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20893084 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16586900 |
| 78 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16483009 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15789530 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14533316 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12635099 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10834837 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08877966 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08616341 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08443827 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08178276 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07420221 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07242485 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06723216 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05853437 |
| 91 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.03195565 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03030838 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01806662 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01360871 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00424132 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99496999 |
| 97 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99432747 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96675918 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95890427 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95063081 |
| 101 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93761467 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91892385 |
| 103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.87817487 |
| 104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87435074 |
| 105 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.86999956 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86204213 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85232132 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83371214 |
| 109 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82661439 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82201781 |
| 111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80309067 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78865519 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.78590263 |
| 114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77130187 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76843140 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75919942 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75643351 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72958423 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72675866 |
| 120 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.70991765 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69443203 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68747376 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68447365 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65728041 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65534040 |
| 126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.64635985 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64632801 |
| 128 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62247382 |
| 129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62157703 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62048660 |
| 131 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60047437 |
| 132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.59712504 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59419930 |
| 134 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58777969 |
| 135 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57635327 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.57549700 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56403458 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56390820 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56299276 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.56095897 |
| 141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55252617 |
| 142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55030669 |
| 143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55030669 |
| 144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54311127 |
| 145 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54011742 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53990843 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52632585 |
| 148 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49966119 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49193793 |
| 150 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.47225334 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47193712 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46598831 |
| 153 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.46177228 |
| 154 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46102623 |
| 155 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45437285 |
| 156 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44308031 |
| 157 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44244976 |
| 158 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43329785 |
| 159 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43171980 |
| 160 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.42162767 |
| 161 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42133510 |
| 162 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.42082076 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41937233 |
| 164 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.40705405 |
| 165 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.40350526 |
| 166 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39729700 |
| 167 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.39601504 |
| 168 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39003427 |
| 169 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.38694417 |
| 170 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37728244 |
| 171 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37540098 |
| 172 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.37467486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14375136 |
| 2 | MP0005360_urolithiasis | 8.05095505 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.33905626 |
| 4 | MP0005365_abnormal_bile_salt | 5.85761980 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.16743737 |
| 6 | MP0003252_abnormal_bile_duct | 4.01755604 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.01520101 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.48191126 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.22457039 |
| 10 | MP0009840_abnormal_foam_cell | 3.15471830 |
| 11 | MP0001666_abnormal_nutrient_absorption | 3.04000530 |
| 12 | MP0005332_abnormal_amino_acid | 2.86261000 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.84522628 |
| 14 | MP0005083_abnormal_biliary_tract | 2.82407225 |
| 15 | MP0003195_calcinosis | 2.73041088 |
| 16 | MP0003303_peritoneal_inflammation | 2.71363715 |
| 17 | MP0003866_abnormal_defecation | 2.46873418 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.46472357 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.41380470 |
| 20 | MP0005671_abnormal_response_to | 2.40308646 |
| 21 | MP0005025_abnormal_response_to | 2.40222072 |
| 22 | MP0001800_abnormal_humoral_immune | 2.39400448 |
| 23 | MP0005387_immune_system_phenotype | 2.36239324 |
| 24 | MP0001790_abnormal_immune_system | 2.36239324 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.27760874 |
| 26 | MP0002419_abnormal_innate_immunity | 2.24379106 |
| 27 | MP0009785_altered_susceptibility_to | 2.20068546 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.17562072 |
| 29 | MP0000685_abnormal_immune_system | 2.08047477 |
| 30 | MP0000609_abnormal_liver_physiology | 2.06457436 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 2.04921309 |
| 32 | MP0002723_abnormal_immune_serum | 2.03427330 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 2.01737842 |
| 34 | MP0001819_abnormal_immune_cell | 1.98764617 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.98476624 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.96977818 |
| 37 | MP0001873_stomach_inflammation | 1.94732767 |
| 38 | MP0006082_CNS_inflammation | 1.90491279 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.80029196 |
| 40 | MP0003868_abnormal_feces_composition | 1.78922697 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.71207822 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.68729203 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.68487778 |
| 44 | MP0001764_abnormal_homeostasis | 1.65928206 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.65371844 |
| 46 | MP0000490_abnormal_crypts_of | 1.58721273 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.56353399 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53659507 |
| 49 | MP0004947_skin_inflammation | 1.53067265 |
| 50 | MP0005451_abnormal_body_composition | 1.52196162 |
| 51 | MP0000716_abnormal_immune_system | 1.50834739 |
| 52 | MP0009697_abnormal_copulation | 1.47981562 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.47856818 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.45131762 |
| 55 | MP0002398_abnormal_bone_marrow | 1.42559639 |
| 56 | MP0008260_abnormal_autophagy | 1.40466574 |
| 57 | MP0005310_abnormal_salivary_gland | 1.34557518 |
| 58 | MP0002405_respiratory_system_inflammati | 1.34546387 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.27955107 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.27563164 |
| 61 | MP0004858_abnormal_nervous_system | 1.27441655 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.25927426 |
| 63 | MP0002722_abnormal_immune_system | 1.23019001 |
| 64 | MP0003011_delayed_dark_adaptation | 1.21138630 |
| 65 | MP0003186_abnormal_redox_activity | 1.18749033 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.14721157 |
| 67 | MP0002429_abnormal_blood_cell | 1.14486412 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 1.13169023 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.12171262 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.11065548 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.10069519 |
| 72 | MP0000598_abnormal_liver_morphology | 1.09951076 |
| 73 | MP0001664_abnormal_digestion | 1.09824522 |
| 74 | MP0002277_abnormal_respiratory_mucosa | 1.09496683 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.09395863 |
| 76 | MP0000477_abnormal_intestine_morphology | 1.05560783 |
| 77 | MP0005409_darkened_coat_color | 1.03971087 |
| 78 | MP0009764_decreased_sensitivity_to | 1.02305511 |
| 79 | MP0002254_reproductive_system_inflammat | 1.01407648 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 1.00692498 |
| 81 | MP0005647_abnormal_sex_gland | 0.97823961 |
| 82 | MP0004147_increased_porphyrin_level | 0.96848106 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.96531289 |
| 84 | MP0000858_altered_metastatic_potential | 0.91228593 |
| 85 | MP0000678_abnormal_parathyroid_gland | 0.90974445 |
| 86 | MP0009763_increased_sensitivity_to | 0.90920632 |
| 87 | MP0003828_pulmonary_edema | 0.89928224 |
| 88 | MP0000604_amyloidosis | 0.89214716 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.87313575 |
| 90 | MP0009278_abnormal_bone_marrow | 0.85814626 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 0.85574452 |
| 92 | MP0008469_abnormal_protein_level | 0.85476137 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.84947331 |
| 94 | MP0004510_myositis | 0.84914716 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.83882445 |
| 96 | MP0008004_abnormal_stomach_pH | 0.81542205 |
| 97 | MP0003448_altered_tumor_morphology | 0.81299539 |
| 98 | MP0002006_tumorigenesis | 0.80292440 |
| 99 | MP0005408_hypopigmentation | 0.78387526 |
| 100 | MP0001756_abnormal_urination | 0.77892710 |
| 101 | MP0004381_abnormal_hair_follicle | 0.77793622 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.77077912 |
| 103 | MP0002822_catalepsy | 0.76587059 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.76206597 |
| 105 | MP0010368_abnormal_lymphatic_system | 0.75847658 |
| 106 | MP0004264_abnormal_extraembryonic_tissu | 0.74650166 |
| 107 | MP0004883_abnormal_blood_vessel | 0.74518827 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.73370110 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.71657617 |
| 110 | MP0002971_abnormal_brown_adipose | 0.68165568 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.66012270 |
| 112 | MP0004043_abnormal_pH_regulation | 0.64569437 |
| 113 | MP0005670_abnormal_white_adipose | 0.63971040 |
| 114 | MP0005266_abnormal_metabolism | 0.63527011 |
| 115 | MP0005334_abnormal_fat_pad | 0.63124009 |
| 116 | MP0005448_abnormal_energy_balance | 0.62373081 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 0.61461260 |
| 118 | MP0005535_abnormal_body_temperature | 0.61076521 |
| 119 | MP0009053_abnormal_anal_canal | 0.61062421 |
| 120 | MP0008872_abnormal_physiological_respon | 0.59280039 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.55726250 |
| 122 | MP0002928_abnormal_bile_duct | 0.53729897 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.53574473 |
| 124 | MP0003718_maternal_effect | 0.53267035 |
| 125 | MP0001661_extended_life_span | 0.52951529 |
| 126 | MP0009379_abnormal_foot_pigmentation | 0.50604840 |
| 127 | MP0004130_abnormal_muscle_cell | 0.50025539 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.49631886 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.48970127 |
| 130 | MP0005395_other_phenotype | 0.47221697 |
| 131 | MP0002796_impaired_skin_barrier | 0.47181044 |
| 132 | MP0003690_abnormal_glial_cell | 0.47000850 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.46991186 |
| 134 | MP0005166_decreased_susceptibility_to | 0.46639290 |
| 135 | MP0003329_amyloid_beta_deposits | 0.45841408 |
| 136 | MP0003724_increased_susceptibility_to | 0.45088222 |
| 137 | MP0008873_increased_physiological_sensi | 0.42926258 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.42571137 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.42562384 |
| 140 | MP0003953_abnormal_hormone_level | 0.42556452 |
| 141 | MP0001663_abnormal_digestive_system | 0.40318182 |
| 142 | MP0000538_abnormal_urinary_bladder | 0.39996736 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.39096798 |
| 144 | MP0009384_cardiac_valve_regurgitation | 0.38580984 |
| 145 | MP0008874_decreased_physiological_sensi | 0.38470613 |
| 146 | MP0002132_abnormal_respiratory_system | 0.38347792 |
| 147 | MP0003436_decreased_susceptibility_to | 0.36475546 |
| 148 | MP0005666_abnormal_adipose_tissue | 0.36300239 |
| 149 | MP0000462_abnormal_digestive_system | 0.36096030 |
| 150 | MP0000579_abnormal_nail_morphology | 0.34841398 |
| 151 | MP0005381_digestive/alimentary_phenotyp | 0.34511018 |
| 152 | MP0010155_abnormal_intestine_physiology | 0.33781682 |
| 153 | MP0005248_abnormal_Harderian_gland | 0.32857261 |
| 154 | MP0001845_abnormal_inflammatory_respons | 0.31681470 |
| 155 | MP0009115_abnormal_fat_cell | 0.31477710 |
| 156 | MP0003075_altered_response_to | 0.31477140 |
| 157 | MP0005167_abnormal_blood-brain_barrier | 0.29456967 |
| 158 | MP0000249_abnormal_blood_vessel | 0.27489256 |
| 159 | MP0001881_abnormal_mammary_gland | 0.26737263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.11466005 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.06491259 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.64115134 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44734748 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.33256181 |
| 6 | Eczematoid dermatitis (HP:0000976) | 6.25309446 |
| 7 | Xanthomatosis (HP:0000991) | 5.95964177 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 5.95846563 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.90778272 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.74433896 |
| 11 | Complement deficiency (HP:0004431) | 4.73388208 |
| 12 | Hyperammonemia (HP:0001987) | 4.65732756 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.59205810 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58561780 |
| 15 | Hyperglycinemia (HP:0002154) | 4.43293829 |
| 16 | Myositis (HP:0100614) | 4.37968390 |
| 17 | Hyperglycinuria (HP:0003108) | 4.32684699 |
| 18 | Joint hemorrhage (HP:0005261) | 4.31012709 |
| 19 | Ketosis (HP:0001946) | 4.28619798 |
| 20 | IgM deficiency (HP:0002850) | 4.27073923 |
| 21 | Epidermoid cyst (HP:0200040) | 4.25875493 |
| 22 | Orchitis (HP:0100796) | 4.24127182 |
| 23 | Fat malabsorption (HP:0002630) | 4.19436458 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18883606 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.17247901 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17247901 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13629113 |
| 28 | Chronic diarrhea (HP:0002028) | 4.12537007 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.11865443 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 4.07672368 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 4.04455256 |
| 32 | Recurrent abscess formation (HP:0002722) | 4.03340792 |
| 33 | Abnormality of B cell number (HP:0010975) | 4.02932221 |
| 34 | Stomatitis (HP:0010280) | 3.99548032 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 3.99468240 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.84629744 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.84534024 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.83506528 |
| 39 | Hypoalphalipoproteinemia (HP:0003233) | 3.81963203 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79754871 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 3.78708980 |
| 42 | Increased IgE level (HP:0003212) | 3.70567350 |
| 43 | B lymphocytopenia (HP:0010976) | 3.67938886 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66541439 |
| 45 | Retrobulbar optic neuritis (HP:0100654) | 3.63559148 |
| 46 | Optic neuritis (HP:0100653) | 3.63559148 |
| 47 | Widely patent fontanelles and sutures (HP:0004492) | 3.59567946 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 3.51873027 |
| 49 | Recurrent fungal infections (HP:0002841) | 3.50195684 |
| 50 | Hypercholesterolemia (HP:0003124) | 3.46079656 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45156078 |
| 52 | Abnormality of complement system (HP:0005339) | 3.44928433 |
| 53 | Gingivitis (HP:0000230) | 3.43654336 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 3.42997825 |
| 55 | Vasculitis (HP:0002633) | 3.39943740 |
| 56 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32518539 |
| 57 | Pustule (HP:0200039) | 3.30563801 |
| 58 | Hyperbilirubinemia (HP:0002904) | 3.30412093 |
| 59 | Thin bony cortex (HP:0002753) | 3.27707975 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 3.26440709 |
| 61 | Ketoacidosis (HP:0001993) | 3.20701288 |
| 62 | Encephalitis (HP:0002383) | 3.17903795 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 3.17880075 |
| 64 | Meningitis (HP:0001287) | 3.09106058 |
| 65 | Gastrointestinal stroma tumor (HP:0100723) | 3.06593940 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 3.06390344 |
| 67 | Delayed CNS myelination (HP:0002188) | 3.04548330 |
| 68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99846776 |
| 69 | Obstructive lung disease (HP:0006536) | 2.99846776 |
| 70 | Metabolic acidosis (HP:0001942) | 2.99267340 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.95644481 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.95616201 |
| 73 | Malnutrition (HP:0004395) | 2.94140610 |
| 74 | Steatorrhea (HP:0002570) | 2.93079325 |
| 75 | Abnormality of T cells (HP:0002843) | 2.91209968 |
| 76 | Gout (HP:0001997) | 2.90538989 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.90277207 |
| 78 | Acanthocytosis (HP:0001927) | 2.83862380 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.83707304 |
| 80 | Spontaneous abortion (HP:0005268) | 2.82503187 |
| 81 | Recurrent bronchitis (HP:0002837) | 2.81580755 |
| 82 | Vascular calcification (HP:0004934) | 2.78873904 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.78836568 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.78836568 |
| 85 | Myocardial infarction (HP:0001658) | 2.76948278 |
| 86 | Lethargy (HP:0001254) | 2.73184830 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.71517954 |
| 88 | Lymphopenia (HP:0001888) | 2.69796498 |
| 89 | Recurrent skin infections (HP:0001581) | 2.69596861 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.65309904 |
| 91 | Abnormality of the peritoneum (HP:0002585) | 2.63441139 |
| 92 | Hypochromic microcytic anemia (HP:0004840) | 2.62594875 |
| 93 | Urticaria (HP:0001025) | 2.61856467 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59730781 |
| 95 | Skin nodule (HP:0200036) | 2.56119380 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.55745702 |
| 97 | Abnormality of T cell number (HP:0011839) | 2.54093747 |
| 98 | Systemic lupus erythematosus (HP:0002725) | 2.52728237 |
| 99 | Chest pain (HP:0100749) | 2.50893813 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.50480621 |
| 101 | Hypochromic anemia (HP:0001931) | 2.49933550 |
| 102 | Cellulitis (HP:0100658) | 2.48255356 |
| 103 | Cardiovascular calcification (HP:0011915) | 2.45936344 |
| 104 | Recurrent sinusitis (HP:0011108) | 2.44998620 |
| 105 | Autoimmune thrombocytopenia (HP:0001973) | 2.44134051 |
| 106 | Hypoglycemic seizures (HP:0002173) | 2.43266903 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.41726695 |
| 108 | Leukocytosis (HP:0001974) | 2.41569850 |
| 109 | Cerebral edema (HP:0002181) | 2.41549368 |
| 110 | Hemoptysis (HP:0002105) | 2.41037919 |
| 111 | Granulocytopenia (HP:0001913) | 2.40771097 |
| 112 | Recurrent cutaneous fungal infections (HP:0011370) | 2.39909750 |
| 113 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.39909750 |
| 114 | T lymphocytopenia (HP:0005403) | 2.36740780 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 2.36717970 |
| 116 | Hydroxyprolinuria (HP:0003080) | 2.36717970 |
| 117 | Recurrent pneumonia (HP:0006532) | 2.35941719 |
| 118 | Irritability (HP:0000737) | 2.35231556 |
| 119 | Prolonged bleeding time (HP:0003010) | 2.34718391 |
| 120 | Late onset (HP:0003584) | 2.34239633 |
| 121 | Spastic diplegia (HP:0001264) | 2.33897703 |
| 122 | Abnormality of the costochondral junction (HP:0000919) | 2.33119521 |
| 123 | Generalized aminoaciduria (HP:0002909) | 2.32774431 |
| 124 | Posterior subcapsular cataract (HP:0007787) | 2.32301176 |
| 125 | Abnormal gallbladder morphology (HP:0012437) | 2.31810489 |
| 126 | Wide cranial sutures (HP:0010537) | 2.29369411 |
| 127 | Cholelithiasis (HP:0001081) | 2.27292133 |
| 128 | IgG deficiency (HP:0004315) | 2.26406079 |
| 129 | Alkalosis (HP:0001948) | 2.25828712 |
| 130 | Glycosuria (HP:0003076) | 2.25066829 |
| 131 | Abnormality of urine glucose concentration (HP:0011016) | 2.25066829 |
| 132 | Proximal tubulopathy (HP:0000114) | 2.24695203 |
| 133 | Vomiting (HP:0002013) | 2.23810173 |
| 134 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.23182570 |
| 135 | Ileus (HP:0002595) | 2.22883559 |
| 136 | Glomerulonephritis (HP:0000099) | 2.22812715 |
| 137 | Neonatal onset (HP:0003623) | 2.21705203 |
| 138 | Sensorimotor neuropathy (HP:0007141) | 2.21205087 |
| 139 | Pancreatitis (HP:0001733) | 2.21176904 |
| 140 | Increased IgM level (HP:0003496) | 2.20671396 |
| 141 | Emphysema (HP:0002097) | 2.19768910 |
| 142 | Abnormal gallbladder physiology (HP:0012438) | 2.19669151 |
| 143 | Cholecystitis (HP:0001082) | 2.19669151 |
| 144 | Petechiae (HP:0000967) | 2.19491771 |
| 145 | Peritonitis (HP:0002586) | 2.18205558 |
| 146 | Pigmentary retinal degeneration (HP:0001146) | 2.18054872 |
| 147 | Eosinophilia (HP:0001880) | 2.17948840 |
| 148 | Rickets (HP:0002748) | 2.17268738 |
| 149 | Poikilocytosis (HP:0004447) | 2.15990214 |
| 150 | Mitral stenosis (HP:0001718) | 2.15314105 |
| 151 | Esophageal varix (HP:0002040) | 2.15014799 |
| 152 | Enlarged kidneys (HP:0000105) | 2.14883461 |
| 153 | Recurrent viral infections (HP:0004429) | 2.14596434 |
| 154 | Skin rash (HP:0000988) | 2.13592587 |
| 155 | Amyloidosis (HP:0011034) | 2.10784189 |
| 156 | Osteomyelitis (HP:0002754) | 2.10056721 |
| 157 | Enlarged epiphyses (HP:0010580) | 2.09486873 |
| 158 | Hypophosphatemia (HP:0002148) | 2.09300095 |
| 159 | Autoimmune hemolytic anemia (HP:0001890) | 2.08648413 |
| 160 | IgA deficiency (HP:0002720) | 2.08622986 |
| 161 | Hyperuricemia (HP:0002149) | 2.07683774 |
| 162 | Increased purine levels (HP:0004368) | 2.07683774 |
| 163 | Brushfield spots (HP:0001088) | 2.06536504 |
| 164 | Anorexia (HP:0002039) | 2.05719552 |
| 165 | Restrictive lung disease (HP:0002091) | 2.04398203 |
| 166 | Abnormality of vitamin B metabolism (HP:0004340) | 2.04029684 |
| 167 | Menorrhagia (HP:0000132) | 2.03670332 |
| 168 | Hypergammaglobulinemia (HP:0010702) | 2.03346165 |
| 169 | Gingival bleeding (HP:0000225) | 2.02961735 |
| 170 | Episodic fever (HP:0001954) | 2.02959285 |
| 171 | Panhypogammaglobulinemia (HP:0003139) | 2.01253144 |
| 172 | Opisthotonus (HP:0002179) | 2.00200904 |
| 173 | Premature loss of primary teeth (HP:0006323) | 1.99076115 |
| 174 | Abnormal cartilage morphology (HP:0002763) | 1.96851663 |
| 175 | Abnormality of vitamin metabolism (HP:0100508) | 1.95790077 |
| 176 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95550525 |
| 177 | Abnormality of the pleura (HP:0002103) | 1.95466340 |
| 178 | Colitis (HP:0002583) | 1.95064195 |
| 179 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94986460 |
| 180 | Hemorrhage of the eye (HP:0011885) | 1.94624812 |
| 181 | Abnormality of the gallbladder (HP:0005264) | 1.94299899 |
| 182 | Hypophosphatemic rickets (HP:0004912) | 1.93705026 |
| 183 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92614297 |
| 184 | Pulmonary embolism (HP:0002204) | 1.91608546 |
| 185 | Thrombophlebitis (HP:0004418) | 1.90490647 |
| 186 | Symptomatic seizures (HP:0011145) | 1.87927919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.48272669 |
| 2 | FGFR4 | 4.25407683 |
| 3 | ERN1 | 4.24634329 |
| 4 | SIK1 | 3.89937046 |
| 5 | RIPK4 | 3.53136985 |
| 6 | MAP4K1 | 3.45598122 |
| 7 | TAOK3 | 3.25633233 |
| 8 | MST1R | 3.24527639 |
| 9 | FRK | 2.86522796 |
| 10 | INSRR | 2.75160414 |
| 11 | ERBB4 | 2.66407154 |
| 12 | ACVR1B | 2.60329912 |
| 13 | IRAK4 | 2.58928526 |
| 14 | NLK | 2.21947368 |
| 15 | PRPF4B | 2.09063411 |
| 16 | MAP3K13 | 2.05609623 |
| 17 | KSR2 | 2.04708823 |
| 18 | MAPK11 | 1.94578242 |
| 19 | BLK | 1.88604301 |
| 20 | PKN2 | 1.86603036 |
| 21 | MAP2K4 | 1.81983958 |
| 22 | ZAP70 | 1.79636254 |
| 23 | JAK3 | 1.79188359 |
| 24 | PTK6 | 1.78033492 |
| 25 | PIK3CG | 1.74935403 |
| 26 | LMTK2 | 1.71889606 |
| 27 | TAOK1 | 1.68273433 |
| 28 | BTK | 1.66858956 |
| 29 | TNK2 | 1.66589212 |
| 30 | LATS1 | 1.65257701 |
| 31 | TXK | 1.61671605 |
| 32 | TYK2 | 1.59951140 |
| 33 | GRK6 | 1.57405307 |
| 34 | HCK | 1.52774572 |
| 35 | IRAK1 | 1.52755905 |
| 36 | SYK | 1.50791317 |
| 37 | FLT3 | 1.43829898 |
| 38 | FES | 1.41952543 |
| 39 | STK38L | 1.40110127 |
| 40 | MAP3K7 | 1.39467688 |
| 41 | ITK | 1.38736857 |
| 42 | DAPK2 | 1.35411743 |
| 43 | MAP2K6 | 1.31234946 |
| 44 | ABL2 | 1.30874258 |
| 45 | ERBB2 | 1.30709586 |
| 46 | NUAK1 | 1.28421185 |
| 47 | TRIB3 | 1.28345229 |
| 48 | PRKAA2 | 1.28121768 |
| 49 | SIK3 | 1.24836030 |
| 50 | NEK9 | 1.23471637 |
| 51 | TESK2 | 1.18051280 |
| 52 | MAP3K10 | 1.16756039 |
| 53 | LCK | 1.15530872 |
| 54 | IRAK3 | 1.13524474 |
| 55 | MAP3K11 | 1.08891639 |
| 56 | TBK1 | 1.07308959 |
| 57 | MET | 1.06755680 |
| 58 | JAK2 | 1.06688948 |
| 59 | WNK4 | 1.06009190 |
| 60 | KDR | 1.03083287 |
| 61 | LYN | 1.03064294 |
| 62 | MAPK15 | 1.01877670 |
| 63 | MAP2K2 | 0.98891965 |
| 64 | PRKG2 | 0.98208567 |
| 65 | RIPK1 | 0.96324930 |
| 66 | TEC | 0.89612310 |
| 67 | MAP3K14 | 0.88536577 |
| 68 | FGFR2 | 0.87376157 |
| 69 | PBK | 0.86637550 |
| 70 | JAK1 | 0.85814746 |
| 71 | SMG1 | 0.85735650 |
| 72 | MATK | 0.85700493 |
| 73 | PRKCZ | 0.84924470 |
| 74 | MAPK4 | 0.84600374 |
| 75 | FGR | 0.82852395 |
| 76 | MAP3K3 | 0.81103486 |
| 77 | YES1 | 0.78639397 |
| 78 | PRKD2 | 0.76907064 |
| 79 | MAP2K3 | 0.76388711 |
| 80 | PRKAA1 | 0.76290453 |
| 81 | EPHB1 | 0.76042787 |
| 82 | DYRK1B | 0.73688356 |
| 83 | PRKACG | 0.73556771 |
| 84 | CDC42BPA | 0.72540680 |
| 85 | PTK2 | 0.71693376 |
| 86 | OXSR1 | 0.71353263 |
| 87 | PINK1 | 0.71071320 |
| 88 | PIK3CA | 0.70784794 |
| 89 | KIT | 0.70079520 |
| 90 | KSR1 | 0.70030080 |
| 91 | CAMK2G | 0.69031522 |
| 92 | IRAK2 | 0.68499021 |
| 93 | CSK | 0.67705139 |
| 94 | GSK3A | 0.67655323 |
| 95 | FYN | 0.64972375 |
| 96 | CDK6 | 0.63430375 |
| 97 | MARK2 | 0.63146364 |
| 98 | WNK3 | 0.61501618 |
| 99 | RET | 0.58292374 |
| 100 | ARAF | 0.58118409 |
| 101 | GRK1 | 0.57767489 |
| 102 | EPHB2 | 0.57684872 |
| 103 | IKBKE | 0.56645225 |
| 104 | SGK3 | 0.56176834 |
| 105 | PDPK1 | 0.56047464 |
| 106 | TIE1 | 0.55533844 |
| 107 | RAF1 | 0.54664716 |
| 108 | IKBKB | 0.54166493 |
| 109 | PIM1 | 0.52925638 |
| 110 | MARK3 | 0.52832565 |
| 111 | PRKCI | 0.52143457 |
| 112 | SIK2 | 0.52129060 |
| 113 | HIPK2 | 0.51947447 |
| 114 | PRKCQ | 0.47985897 |
| 115 | MAP2K1 | 0.47043050 |
| 116 | MAPK12 | 0.46108278 |
| 117 | PDK4 | 0.45984292 |
| 118 | PDK3 | 0.45984292 |
| 119 | MYLK | 0.44766017 |
| 120 | BMPR2 | 0.44257557 |
| 121 | MAP3K1 | 0.43933762 |
| 122 | CDK19 | 0.43812582 |
| 123 | MAP3K2 | 0.42839224 |
| 124 | AKT3 | 0.42632940 |
| 125 | MAP3K9 | 0.40221940 |
| 126 | CAMKK1 | 0.39282310 |
| 127 | CAMK1D | 0.36146416 |
| 128 | CDK4 | 0.35883537 |
| 129 | EPHA3 | 0.35181733 |
| 130 | PTK2B | 0.35109088 |
| 131 | PRKCA | 0.35026357 |
| 132 | TGFBR2 | 0.34832520 |
| 133 | SGK2 | 0.34807831 |
| 134 | STK11 | 0.33678364 |
| 135 | CSNK1G1 | 0.32365920 |
| 136 | PDK1 | 0.31622150 |
| 137 | MAP3K8 | 0.31104627 |
| 138 | SGK223 | 0.31078235 |
| 139 | SGK494 | 0.31078235 |
| 140 | MAP3K6 | 0.30484783 |
| 141 | IGF1R | 0.30395812 |
| 142 | FGFR3 | 0.28387047 |
| 143 | EPHA2 | 0.28335137 |
| 144 | MAPK7 | 0.28164280 |
| 145 | STK39 | 0.24157692 |
| 146 | BMX | 0.22635356 |
| 147 | CSF1R | 0.22557079 |
| 148 | ICK | 0.21436654 |
| 149 | EPHA4 | 0.21323753 |
| 150 | TAOK2 | 0.21231854 |
| 151 | MTOR | 0.21149217 |
| 152 | NME1 | 0.19224933 |
| 153 | CAMK4 | 0.18978906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.15519582 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.51396844 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42545397 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04914472 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91330428 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.76845072 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64555520 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.61112620 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54057890 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52546589 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43412430 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42611223 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41971598 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41336195 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26487908 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.23628252 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16810213 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12647773 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10995214 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09275504 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.07236141 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03614549 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99378247 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94533516 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93261238 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89573626 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87725696 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87225929 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84802850 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79075774 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77360586 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.76333473 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74763328 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72994975 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69132823 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65708943 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65364720 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.63713525 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63152457 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62999719 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59226793 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58315159 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56874274 |
| 44 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56763615 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55732443 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52380160 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50034551 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49653235 |
| 49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47497936 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.45524928 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.45306144 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44122680 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42227537 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37156532 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37100702 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36511870 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35439321 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33435580 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30614701 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26716618 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.25965429 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25524583 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24581683 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 1.21724352 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21313484 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20995582 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20606935 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20447758 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19123740 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17487133 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16055077 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14121760 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13796986 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13345024 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11456276 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11430728 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09615325 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07560935 |
| 79 | Measles_Homo sapiens_hsa05162 | 1.06244442 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 1.04202707 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02813617 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98159429 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97071583 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96647201 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96191520 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92244657 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90460040 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89798683 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88380320 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.85081733 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81711147 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.81417264 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80173578 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79490740 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.79151963 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78568178 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77926902 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77617050 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74157674 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71909355 |
| 101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70481941 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.70106871 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69365022 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64932452 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64115549 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60902509 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58552168 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.58518405 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55598081 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54541658 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.52436698 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52285541 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50578954 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49868158 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.49307991 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48866912 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48186977 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47342916 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.46640649 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45891922 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44779626 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43972254 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.43629134 |
| 124 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43346786 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39984450 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35813366 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35800018 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35136226 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34695490 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34644083 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.33743778 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33607992 |
| 133 | Shigellosis_Homo sapiens_hsa05131 | 0.33278301 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32478404 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32166625 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23428442 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.19837010 |
| 138 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17948186 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17899917 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.17324006 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15563584 |
| 142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14044346 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.11791495 |
| 144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08708175 |
| 145 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08437527 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03420257 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02328039 |
| 148 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2338232 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2316398 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2298175 |
| 151 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.2278150 |
| 152 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2122017 |
| 153 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2062421 |
| 154 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1877363 |
| 155 | Bladder cancer_Homo sapiens_hsa05219 | -0.1812507 |
| 156 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1647426 |
| 157 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1533793 |
| 158 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1461167 |
| 159 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1199227 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | -0.1158263 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1144270 |
| 162 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0638924 |
| 163 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0265556 |
| 164 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0093541 |

